Metrics to compare | 002030 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002030PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.4x | −16.3x | −0.3x | |
PEG Ratio | 0.12 | −0.03 | 0.00 | |
Price/Book | 1.1x | 3.5x | 2.6x | |
Price / LTM Sales | 10.2x | 8.5x | 3.0x | |
Upside (Analyst Target) | - | 35.8% | 56.6% | |
Fair Value Upside | Unlock | 5.2% | 10.2% | Unlock |
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections sexually transmitted infections, human immunodeficiency virus, blood screening, respiratory infections, digestive pathogens, public health, coronavirus disease (COVID-19), tumor marker, pharmacogenomics, nucleic acid extraction, and viral transport medium (VTM) collection kits. It also provides molecular diagnostic instruments comprising PCR detection systems, nucleic acid extraction systems, and sample transfer processing systems. In addition, the company offers immunoassay test kits that include COVID-19 rapid test kits; pathology tests, such as liquid based cytology production and automatic sample transfer machines; and auto biochemistry analyzers. It sells its products under the Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech brands. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. Daan Gene Co., Ltd. was incorporated in 1988 and is headquartered in Guangzhou, China.